Adrenergic reactivity after inhibition of nitric oxide synthesis in the cerebral circulation of awake goats

Brain Research

Volumn 813, Issue 2, 1998, Pages 381-389

  Diéguez, Godofredo ^a   Fernández, Nuria ^a   Sánchez, Miguel Angel ^a   García Villalón, Angel Luis ^a   Monge, Luis ^a   Gómez, Bernardino ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Adrenergic activity; Cerebral blood flow; Cerebrovascular conductance; Norepinephrine; Sympathetic stimulation

Indexed keywords

NITRIC OXIDE;

ADRENERGIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN BLOOD FLOW; GOAT; NONHUMAN; NORADRENALIN BRAIN LEVEL; PRIORITY JOURNAL; SYMPATHETIC TONE; WAKEFULNESS;

ANIMALS; CEREBRAL CORTEX; CEREBROVASCULAR CIRCULATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; ELECTROMAGNETIC FIELDS; ENZYME INHIBITORS; FEMALE; GOATS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NOREPINEPHRINE; RECEPTORS, ADRENERGIC; SYMPATHETIC NERVOUS SYSTEM; SYMPATHOMIMETICS; TYRAMINE; WAKEFULNESS;

EID: 17044441024     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)01064-6     Document Type: Article

References (37)

1. Aldasoro A., Martínez C., Vila J.M., Medina P., Lluch S. Influence of endothelial nitric oxide on adrenergic contractile responses of human cerebral arteries. J. Cereb. Blood Flow Metab. 16:1996;623-628.
2. Bauknight G.C., Faraci F.M., Heistad D.D. Endothelium-derived relaxing factor modulates noradrenergic constriction of cerebral arterioles in rabbits. Stroke. 23:1992;1522-1526.
3. Bill A., Linder J. Sympathetic control of cerebral blood flow in acute arterial hypertension. Acta Physiol. Scand. 96:1976;114-121.
4. G-nitro-L-arginine methyl ester and other alkyl esters of arginine are muscarinic receptor antagonists. Circ. Res. 72:1993;387-395.
5. Conde M.V., Marín J., Salaíces M., Marco E.J., Gómez B., Lluch S. Adrenergic vasoconstriction of the goat middle cerebral artery. Am. J. Physiol. 235:1978;H131-H135.
6. Daniel P.M., Dawes J.D.K., Prichard M.M.L. Studies of the carotid rete and its associated arteries. Philos. Trans. R. Soc. London. 237:1953;173-208.
7. Diéguez G., Conde M.V., Gómez B., Iglesias J.R., Marín J., Lluch S. Rete mirabile of goat: in vitro effects of adrenergic stimulation. Brain Res. 289:1983;281-284.
8. Diéguez G., García J.L., Fernández N., García-Villalón A.L., Monge L., Gómez B. Role of NO in goat basal cerebral circulation and after vasodilatation to hypercapnia or brief ischemias. Am. J. Physiol. 265:1993;R1410-R1415.
9. Diéguez G., García-Villalón A.L., Gómez B., Lluch S. Hemodynamic significance of the carotid rete during changes in arterial blood pressure. Am. J. Physiol. 254:1988;R770-R775.
10. Dun N.J., Dun S.L., Wu S.Y., Förstemann U. Nitric oxide synthase immunoreactivity in rat superior cervical ganglia and adrenal glands. Neurosci. Lett. 158:1993;51-54.
11. L. Edvinsson, E.T. MacKenzie, J. McCulloch, Adrenergic mechanisms, in: L. Edvinsson, E.T. MacKenzie, J. McCulloch (Eds.), Cerebral Blood Flow and Metabolism, Raven Press, New York (1993), pp. 183-320.
12. Faraci F.M., Brian J.E. Nitric oxide and the cerebral circulation. Stroke. 25:1994;692-703.
13. Fernández N., García J.L., García-Villalón A.L., Monge L., Gómez B., Diéguez G. Cerebral blood flow and cerebrovascular reactivity after inhibition of nitric oxide synthesis in conscious goats. Br. J. Pharmacol. 110:1993;428-434.
14. Fernández N., Monge L., García J.L., García-Villalón A.L., Gómez B., Diéguez G. In vivo and in vitro action of endothelin-1 on goat cerebrovascular bed. Eur. J. Pharmacol. 348:1998;199-211.
15. Hansen J., Jacobsen T.N., Victor R.G. Is nitric oxide involved in the tonic inhibition of cerebral sympathetic outflow in humans? Hypertension. 24:1994;439-444.
16. Kauser K., Rubanyi G.M. Gender difference in bioassayable endothelium-derived nitric oxide from isolated rat aortae. Am. J. Physiol. 267:1994;H2311-H2317.
17. G-nitro-L-arginine methyl ester. Brain Res. 639:1994;309-312.
18. G-nitro-L-arginine and L-arginine on regional cerebral blood flow in the cat. J. Physiol. 449:1992;183-196.
19. Lacolley P.J., Lewis S.J., Brody M.J. Role of sympathetic nerve activity in the generation of vascular nitric oxide in urethane-anesthetized rats. Hypertension. 17:1991;881-887.
20. Lautt W.W. Resistance or conductance for expression of arterial vascular tone. Microvasc. Res. 37:1989;230-236.
21. Lluch S., Diéguez G., García A.L., Gómez B. Rete mirabile of goat: its flow-damping effect on cerebral circulation. Am. J. Physiol. 249:1985;R482-R489.
22. Lluch S., Gómez B., Alborch E., Urquilla P.R. Adrenergic mechanisms in cerebral circulation of the goat. Am. J. Physiol. 228:1975;985-989.
23. Lluch S., Reimann C., Glick G. Evidence for the direct effect of adrenergic drugs on the cerebral vascular bed of the unanesthetized goat. Stroke. 4:1973;50-56.
24. Moncada S., Palmer R.M.J., Higgs E.A. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev. 43:1991;109-142.
25. Miletich D.J., Ivankovic A.D., Albrech R.F., Toyooka E.T. Cerebral hemodynamics following internal maxillary artery ligation in the goat. J. Appl. Physiol. 38:1975;942-945.
26. Reimann C., Lluch S., Glick G. Development and evaluation of an experimental model for the study of the cerebral circulation in the unanesthetized goat. Stroke. 3:1972;322-328.
27. w-nitro-L-arginine methyl ester. Hypertension. 30:1997;64-70. Part 1.
28. Stallone J.N. Role of endothelium in sexual dimorphism in vasopressin-induced contraction of rat aorta. Am. J. Physiol. 265:1993;H2073-H2080.
29. Thomas C.L., Kelly P.A.T., Ritchie I.M., Sharkey J., Arbuthnott G.W. Cerebrovascular autoregulation to hypertension induced by inhibition of nitric oxide synthesis. Br. J. Pharmacol. 108:1993;129P.
30. Toda N., Okamura T. Role of nitric oxide in neurally induced cerebroarterial relaxation. J. Pharmacol. Exp. Ther. 258:1991;1027-1032.
31. Urquilla P.R., Marco E.J., Balfagón B., Lluch S. Adrenergic mechanisms in cerebral blood vessels: effect of tyramine on the isolated middle cerebral artery of the goat. Stroke. 5:1974;447-452.
32. Vanhoutte P.M., Rubanyi G.M., Mille V.M., Houston D.S. Modulation of vascular smooth muscle contraction by the endothelium. Annu. Rev. Physiol. 48:1986;307-320.
33. Vo P.A., Reid J.J., Rand M.J. Attenuation of vasoconstriction by endogenous nitric oxide in rat caudal artery. Br. J. Pharmacol. 107:1992;1121-1128.
34. Wagerle L.C., Moliken W., Russo P. Nitric oxide and beta-adrenergic mechanisms modify contractile responses to norepinephrine in ovine fetal and newborn cerebral arteries. Pediatr. Res. 38:1995;237-242.
35. Wang Q., Pulson O.B., Lasen N.A. Is autoregulation of cerebral blood flow in rats influenced by nitro-L-arginine, a blocker of the synthesis of nitric oxide? Acta Physiol. Scand. 145:1992;297-298.
36. Yamamoto R., Wada A., Asada Y., Uhi T., Yanagita T., Niina H., Sumihoshi A. Functional relation between nitric oxide and norepinephrine for the modulation of vascular tone in rat mesenteric vasculature. Naunyn-Schmiedeberg's Arch. Pharmacol. 349:1994;362-366.
37. Zanzinger J., Czachurski J., Seller H. Inhibition of sympathetic vasoconstriction is a major principle of vasodilation by nitric oxide in vivo. Circ. Res. 75:1994;1073-1077.